Author: Jishnu Nair

Baylor College of Medicine is set to anchor one of Texas Medical Center’s buildings in its upcoming life sciences campus, Helix Park

 A Houston biotech company closed its initial public offering at the start of 2023 with plans to advance clinical trial development.

 Coya Therapeutics is set to take $13 million in net proceeds following the closing of its IPO on Jan. 4. The offering…

The opening marks the latest milestone of Kelsey-Seybold expansions and constructions in the Houston area.

Previously, CNS Pharmaceuticals CEO John Climaco also held the role of chairman.

Although tech layoffs increased in 2022, moves at the C-suite level in Houston continued. Here are the names in Houston tech that moved this year.

With Houston growing as a startup ecosystem, new initiatives to aid founders targeted demographics and local industries

Several weeks after filing for an IPO, a Houston biotech firm has announced pricing for its shares with the offering running through early January.

All stages of venture capital investing took a hit in 2022 compared to 2021 amid wider economic strains, but some Houston companies managed to get significant funding deals across the finish line.

San Jacinto College and Houston-based McCord Development, the developer of Generation Park, signed a memorandum of understanding with Irish nonprofit National Institute for Bioprocessing Research and Training for the new center.

A new report by careers site Dice shows that despite nationwide tech layoffs, the Bayou City is leading the way among U.S. cities in tech jobs